These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33775446)

  • 1. Conceptualizing stigma in contexts of pregnancy and opioid misuse: A qualitative study with women and healthcare providers in Ohio.
    Syvertsen JL; Toneff H; Howard H; Spadola C; Madden D; Clapp J
    Drug Alcohol Depend; 2021 May; 222():108677. PubMed ID: 33775446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conceptualizing Neonatal Abstinence Syndrome as a Cascade of Care: A Qualitative Study With Healthcare Providers in Ohio.
    Syvertsen JL; Toneff H; Madden DR; Clapp JD
    Adv Neonatal Care; 2018 Dec; 18(6):488-499. PubMed ID: 30234507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Will My Baby Be OK?" A Qualitative Analysis of Pregnant Women's Suboxone
    Moore DJ; Butzlaff A
    J Am Psychiatr Nurses Assoc; 2023; 29(3):185-193. PubMed ID: 37038973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
    Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M
    Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal buprenorphine treatment and infant outcome.
    Jansson LM; Velez ML; McConnell K; Spencer N; Tuten M; Jones H; Rios R; King VL; Gandotra N; Millio L; DiPietro JA
    Drug Alcohol Depend; 2017 Nov; 180():56-61. PubMed ID: 28869859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
    O'Connor AB; Collett A; Alto WA; O'Brien LM
    J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.
    Noormohammadi A; Forinash A; Yancey A; Crannage E; Campbell K; Shyken J
    Ann Pharmacother; 2016 Aug; 50(8):666-72. PubMed ID: 27199497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma.
    Holbrook AM
    Am J Drug Alcohol Abuse; 2015; 41(5):371-3. PubMed ID: 26154531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Neonatal Abstinence Syndrome in an Outpatient Prenatal Buprenorphine Tapering Program.
    Olsen M
    South Med J; 2020 Nov; 113(11):553-558. PubMed ID: 33140108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure.
    Nguyen L; Lander LR; O'Grady KE; Marshalek PJ; Schmidt A; Kelly AK; Jones HE
    Am J Addict; 2018 Mar; 27(2):92-96. PubMed ID: 29473258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
    Johnson S; Martin PR
    Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.
    Brogly SB; Saia KA; Walley AY; Du HM; Sebastiani P
    Am J Epidemiol; 2014 Oct; 180(7):673-86. PubMed ID: 25150272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could prenatal food insecurity influence neonatal abstinence syndrome severity?
    Rose-Jacobs R; Trevino-Talbot M; Lloyd-Travaglini C; Cabral HJ; Vibbert M; Saia K; Wachman EM
    Addiction; 2019 Feb; 114(2):337-343. PubMed ID: 30422365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome.
    Jones HE; Kraft WK
    Clin Perinatol; 2019 Jun; 46(2):349-366. PubMed ID: 31010564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a canadian multisite cohort study.
    Ordean A; Kahan M; Graves L; Abrahams R; Kim T
    J Obstet Gynaecol Can; 2015 Mar; 37(3):252-257. PubMed ID: 26001872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.